Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 7:03 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 673–696 of 2,510 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: RAPID Clear all

Conditions: Congenital Lactic Acidosis
Interventions: Dichloroacetate (DCA), Genetic Marker on Chromosome 14q24.3; Drug · Genetic
Lead sponsor: University of Florida; Other
Eligibility: 21 Years to 50 Years
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Acute Kidney Injury
Interventions: Creatine Monohydrate, Creatine Ethyl Ester; Dietary Supplement
Lead sponsor: Beth Israel Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: New York, New York

Conditions: Opioid Use Disorder
Interventions: EMBED CDS, Nurse prompt to complete COWS, Provider Prompt, Patient facing materials, Optimized EMBED, Name of Intervention; Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 1,912 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 3
States / cities: Guilford, Connecticut • New Haven, Connecticut

Conditions: Contraception
Interventions: Copper IUD, Levonorgestrel IUD; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 711 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 6
States / cities: Logan, Utah • Ogden, Utah • Orem, Utah + 3 more

Conditions: Septic Shock
Interventions: Levo-Carnitine, placebo; Drug
Lead sponsor: University of Mississippi Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 14
States / cities: Birmingham, Alabama • Sacramento, California • Wilmington, Delaware + 9 more

Conditions: Off-shift Robotic Telerounding
Interventions: Remote physician rounding; Behavioral
Lead sponsor: Lahey Clinic; Other
Eligibility: 18 Years to 75 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Burlington, Massachusetts

Conditions: PTSD, Rape Sexual Assault
Interventions: Rapid Resolution Therapy; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Diabete Type 2, Obesity & Overweight, Nutritional Intervention, Food Insecurity
Interventions: Meal kits, No-prep meals, Culinary nutrition classes, Text messages; Behavioral
Lead sponsor: Tufts University; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Cognitive Ability, General, Dietary Modification
Interventions: SLOW Carbohydrate, MEDIUM Carbohydrate, FAST Carbohydrate; Other
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 9 Years to 10 Years
Enrollment: 113 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2012
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Driving Distress Secondary to Trauma During Deployment
Interventions: Cognitive reappraisal and breathing retraining, Control; Behavioral
Lead sponsor: Palo Alto Veterans Institute for Research; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Pediatric Low-grade Gliomas
Interventions: Wave-CAIPI; Other
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 0 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2028
U.S. locations: 3
States / cities: Boston, Massachusetts

Conditions: Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus, T/NK-lymphoproliferative Disease, Nasopharyngeal Carcinoma, Smooth Muscle Tumor
Interventions: MABEL CTLs, Cyclophosphamide, Fludarabine; Biological · Drug
Lead sponsor: Baylor College of Medicine; Other
Eligibility: Not listed
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2029
U.S. locations: 2
States / cities: Houston, Texas

Conditions: Schizophrenia
Interventions: Asenapine, Placebo Asenapine, Olanzapine, Placebo Olanzapine; Drug
Lead sponsor: Forest Laboratories; Industry
Eligibility: 18 Years and older
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Wound Chronic Draining, Wound Closure
Interventions: Platelet-rich fibrin (PRF); Device
Lead sponsor: Estar Medical dba Medical Technologies, LTD; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 3
States / cities: Bradenton, Florida • San Antonio, Texas

Conditions: Biological Specimens
Interventions: Not listed
Lead sponsor: National Institute of Environmental Health Sciences (NIEHS); NIH
Eligibility: 21 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Research Triangle Park, North Carolina

Conditions: Monoclonal Gammopathy of Undetermined Significance, Plasma Cell Myeloma
Interventions: 5-Carbon C 13-labeled Glutamine, Biospecimen Collection, Uniformly-labeled [13C]glucose; Other · Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Healthy Volunteer
Interventions: Alectinib, Esomeprazole, High Fat and Calorie Meal, Standard Meal; Drug · Other
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Breast Cancer
Interventions: Weight Loss; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 65 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Aurora, Colorado

Conditions: Colon Cancer
Interventions: PalloV-CC; Biological
Lead sponsor: George E. Peoples; Industry
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: PreDiabetes
Interventions: Ad libitum meal timing, Twice a day meals; Other
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 30 Years to 70 Years · Male only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Homocystinuria
Interventions: SYNB1353; Drug
Lead sponsor: Synlogic; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: High Point, North Carolina

Conditions: Focal Dystonia, Healthy Volunteers
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 80 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cardiovascular Diseases
Interventions: MBCT-T, Booster Mindfulness Sessions, Website Support; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Walking, Difficulty, Mobility Limitation
Interventions: FAST (Functional Activity Strength Training), Band Together, Behavioral Change Technique; Behavioral
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 65 Years and older
Enrollment: 702 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Search by objective public record fields.

Pharmacotoxicology of Trichloroethylene Metabolites

Effect of Creatine on Serum and Urine Creatinine

Adaptive Decision Support for Addiction Treatment Master

RAPID EC - Rct Assessing Pregnancy With Intrauterine Devices for EC

Rapid Administration of Carnitine in sEpsis

The Role of Off-shift Robotic Telerounding Between Physicians and Nurses in the Surgical Intensive Care Unit

RRT for PTSD Symptoms in Survivors of Sexual Violence

Nutrition Intervention Optimization to Better Utilize Resources and Support Health

The Acute Effects Fortified Nutritional Supplementation on Childhood Cognition

Enhancing Emotion Regulation During Driving in OEF/OIF Veterans

Developing Fast Pediatric Imaging

Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)

Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689)

Using TropoCells(R) Autologous Platelet-Rich Fibrin (PRF) to Treat Chronic Non-Healing Wounds

Rapid Acquisition of Pre- and Post-Incident Disaster Data

Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma

A Study Investigating the Effect of Food and Esomeprazole on the Single Oral Dose Pharmacokinetics of Alectinib (RO5424802) in Healthy Volunteers.

4:3 Intermittent Fasting Intervention in Adults With Breast Cancer and Overweight or Obesity

Trial of PalloV-CC in Colon Cancer

2-A-Day Study: Twice a Day Meals Study.

Safety, Tolerability and Pharmacodynamics of SYNB1353 in Healthy Adult Volunteers

Depotentiation in People With Focal Hand Dystonia

HARP Mindfulness Study

Testing Interventions for Mobility Through Exercise (TIME)